Gene expression profiling by cDNA array analysis in melanoma is hampered by the need for large amounts of RNA to prepare reliable probes for array hybridization. On the other hand, for ex vivo analysis of malignant cells from melanocytic tumors laser pressure catapulting is an essential prerequisite to obtain noncontaminated melanocytic preparations; however, laser pressure catapulting prepared material provides only nanogram amounts of RNA. In this study we present an approach to overcome these limitations by combining laser pressure catapulting and realtime polymerase chain reaction based SMART cDNA amplification technology. Reproducible and reliable hybridization patterns from about 500 laser pressure catapulting prepared cell equivalents from 22 cases of melanocytic tumors were generated using array analysis. Univariate analysis revealed significant differences of the expression pattern of melanocytic nevi, melanomas, and melanoma metastases. Multivariate analysis with four genes being the best univariate discriminative features (tyrosinase related protein 2, translation initiation factor 2c, ubiquitine conjugating enzyme E2I and one expressed sequence tag) allowed clustering of nevi, melanomas, and melanoma metastases with an accuracy of 82%. Data validation was performed by additional quantitative reverse transcription-polymerase chain reaction (TaqMan-reverse transcription-polymerase chain reaction). Taken together, this study shows, that (1) array analysis is feasible on tumors with rather low cell numbers, and (2) differences in expression profiles allow discrimination between benign and malignant lesions. Expression patterns of marker genes defined in unequivocal histopathologic entities may improve the diagnostic and prognostic assessment of difficult melanocytic lesions, which is still the hardest problem in dermatopathology.
The discrimination between benign and malignant melanocytic lesions is often conjectural. Furthermore, if a lesion is diagnosed as melanoma, it would be highly desirable to supplement the pathology with molecular markers discriminating potentially metastatic and nonmetastatic biologic phenotypes more precisely. Molecular markers, which were previously used (e.g., p53, Ki67, cathepsins, collagenase, c-fos, c-myc) have some prognostic value but due to conjectural results none of those has made it into clinical routine (Vogt et al, 1997) . Therefore, establishing a technique enabling the analysis of multiple parameters simultaneously is crucial in order to expand the knowledge on known potential markers and add new ones.
The development of melanoma is a process, in which the cellular homeostasis is dramatically changed by the deregulation of the expression of many genes (Herlyn et al, 2001) . These complex changes can now be analyzed by genomewide profiling techniques, such as the cDNA array hybridization for generating the desired marker profiles. Cancer research, however, in this specific entity and in others with small amounts of tumor cells was hitherto hampered by the excessive amounts of RNA necessary to produce reliable probes for array hybridization (Bertucci et al, 1999) . There-fore, the majority of tumors analyzed by array or chip analyses were either metastases (Bittner et al, 2000) or tumor entities, which harbor enough tumor tissue for purification of sufficient amounts of RNA (Alizadeh et al, 2000; Dhanasekaran et al, 2001; Young et al, 2001; Ahr et al, 2002) . Alternatively, cells from fresh tumor biopsies were taken in culture for several passages before preparing RNA from these cultured cells (Bittner et al, 2000; Brem et al, 2001) , but the molecular ''proximity'' to the original tumor is questionable.
The tumor cells in nevi or early melanomas may constitute only a minor fraction of the total tissue volume excised during surgery. Isolation of the melanocytic cells from small early lesions by conventional microdissection techniques might include variable numbers of contaminating nonmelanoma cells. The Laser Pressure Catapulting (LPC) microscope allows to isolate directly and analyze small cell populations of interest virtually without any contaminating cells directly from hematoxylin and eosin stained histologic sections (Bohm et al, 1997; Schutze and Lahr, 1998; Westphal et al, 2002) . As only low amounts of RNA can be gained from LPC prepared cells, amplification of the RNA is a prerequisite for array analysis. Methods involving RNA amplification based on T7-primed in vitro transcription were shown to generate reliable results in studies of neuronal cells and early colorectal carcinomas (Luo et al, 1999; Kitahara et al, 2001) . The procedures involved, however, are rather time-consuming and expensive and may therefore be not applicable for routine purposes. We have recently shown a fast and inexpensive polymerase chain reaction (PCR)-based alternative approach that seems to be much more suitable for routine applications (Becker et al, 2001) and applied this technique to RNA from LPC-prepared melanocytic cells.
Results
Reproducibility of array hybridization experiments coupled to LPC and SMART To demonstrate the reproducibility of our method, we performed the analysis of four of our cases as independent duplicate experiments (case nos 2, 9, 18, and 21; Table I ). A typical result of one of the experiments is shown in Fig 1(b) . For the pairwise comparison an expression threshold for a significant signal intensity was set as described (e.g., no. 2068-1 and no. 2068-2, Fig 1b: yellow lines) . Genes below these thresholds are not taken into account because of an increased probability of giving false positive results because of low signal-to-background ratios (Fig 1b: yellow spots); 2.2% of the detected genes appeared as ''regulated''. These genes represent false positives (Fig 1b: blue spots above the red line and below the green line). The remaining signals (97.8%, 270 of 4467 genes displayed on the array) are evenly expressed in this duplicate experiment (Fig 1b: blue spots between the red and the green lines). The average rate of false positive regulated genes in four independent experiments was 6.9% (2.2% of 270 genes, 2.2% of 410, 10.3% of 77, and 13% of 84).
Observed categories of regulation during progression of melanocytic lesions For assessment of the proportions and sizes of classes of regulated genes during melanoma progression, all regulated genes were clustered into four regulative categories according to the pattern of regulation during progression from nevi versus melanoma versus melanoma metastases as described above. These major regulative categories were further split with regard to their functional context, based on the recent knowledge in the literature: (1) metabolism; (2) signaling/cell cycle; (3) receptors/attachment; (4) others with known function; and (5) unknown function. The absolute number of genes regulated in the different functional clusters are summarized in Fig 2. As expected, the most prominent differences in gene expression profiles of known genes was observed in the category ''metabolism'' showing upregulation in melanomas versus nevi (Fig 2, light gray) . The average expression ratios of the genes included in the analysis and their categories are summarized in a detailed table, which is available as supplemental material.
Classification of nevi, melanomas, and melanoma metastases We analyzed the melanocytic tumors listed in Table I by array analysis. From 4467 spotted genes, 232 passed the filter an expression threshold of 5%, averaged over all cases. Univariate analysis revealed those genes that were statistically significantly regulated in different stages of progression. The genes with the highest F-values from Case nos 1 to 22 were used for array analysis; case nos 23 to 35 were used as further validation set for reverse transcription-PCR. SSM, superficial spreading melanoma; NMM, nodular melanoma; LMM, lentigo maligna melanoma.
Figure 1
(a) A typical protocol during SMART cDNA amplification PCR with two different templates recorded with the Rotor-Gene realtime PCR machine. The marks A and B label the number of cycles used for equal amplification of the templates; 22 and 25 cycles, respectively. ÀRT represents the control reaction without reverse transcriptase during the first-strand synthesis step in the SMART protocol. The inset shows an agarose gel with the cDNA isolated from template A after 22 cycles and template B after 25 cycles; on the lane labeled ÀRT the negative control is shown. Equal volumes from the cDNA and the negative control were loaded on each lane. M: DNA size marker (sizes given in kb). (b) Array comparison dotplot of two arrays hybridized with probes generated from two independent LPC preparations from sections on two slides of the same biopsy (no. 2068). After data analysis with AIDA matrix the pairwise comparison of the normalized expression data was performed by the AIDA compare module. The detection threshold was set to 16% and 15% for no. 2068-1 and 2068-2, respectively. The green and red line represents 3-fold downregulation or upregulation, respectively.
Figure 2
Numbers of genes regulated during progression of melanocytic lesions clustered according to functional groups. Sorted according to the pattern of regulation: (1) induction from nevi towards melanoma (light gray); (2) induction from melanoma towards metastases (gray); (3) induction from nevi towards melanoma and further upregulation towards metastases (dark gray); (4) genes upregulated from nevi towards melanoma and subsequently suppressed in metastases (black). The groups contain the following gene functions: Metabolism, signaling/cell cycle, receptors/attachment, others, unknown function. univariate analysis are listed in Table II sorted according to their statistical relevance. Multivariate stepwise analysis of the cases using those four most significant univariate variables allowed classification of 82% of all cases correctly in accordance to the expert histopathologic diagnosis (Table IIIA) . The resulting clusters of lesions are displayed by plotting the canonical discriminant functions for each case in Fig 3. This plot visualizes the relative distances of the profiles using this set of four most discriminative variables. For those four genes the average expression value within each class of melanocytic lesion was calculated (Table II) .
To verify the array data classification results, we analyzed the expression of the marker genes shown in Table II by quantitative real-time reverse transcription-PCR using Taq-Man probes. In addition to the genes used for classification, we included in this analysis a further eight genes that reached the highest F-values in the univariate analysis. In order to assure, that the markers are valid independent of the set of lesions selected, the expression was analyzed in another set of melanocytic lesions (three nevi, five melanomas, and five melanoma metastases, Table I : case nos 23-35). The expression values were normalized to GAPDH expression. The normalized expression levels of three genes (eIF2g, UBE2I, and the EST) were analyzed statistically by the same canonical discriminant analysis as used for the array data. According to the histopathologic diagnosis 85% of all cases could be classified correctly (Table IIIB) . The comparison of the expression values obtained by reverse transcription-PCR with the regulation observed in array analysis verifies the mode of regulation from benign towards malignant lesions in nine of 12 genes (Table IV) .
Discussion
Gene expression profiles of melanoma cells were so far restricted to advanced tumors harboring microgram amounts of RNA or which were taken into culture from the tumors and passaged several times to get enough cells for RNA isolation (Bittner et al, 2000; Brem et al, 2001) . In contrast to the analysis of primary tumor material, the analysis of cultured tumor cells might bear misleading results due to adaptive effects under cell culture conditions. The LPC-microdissection real-time SMART-PCR approach presented herein, overcomes these limitations. We demonstrate that with this approach gene expression analysis of melanocytic cells isolated directly from routinely excised biopsy material is fast and reasonably inexpensive.
By statistical analysis of the expression profiles of melanocytic lesions we obtained a set of potential markers (Table II) , which discriminates melanocytic tumors of different levels of malignancy with an accuracy of 82%, if compared with histopathology evaluation (Table III, Fig 3) . The few falsely classified lesions might represent certain subsets of biologic phenotypes characterized by gene expression changes outside of the typical range, which are not recognizable by histopathology. This set of marker genes could be further validated by quantitative reverse transcription-PCR on a second set of melanocytic tumors, reaching the same accuracy of 85% correctly classified cases (Table III) , although for statistical significance reasons only three variables were included in the canonical discriminant analysis. In addition, we analyzed a further eight genes with the highest F-values from the univariate analysis in the same set of lesions by reverse transcription-PCR to validate the array results more stringently. Nine of 12 genes could be confirmed (Table IV) . This result is even more convincing, as the analyses were performed in two different sets of melanocytic lesions.
The small amounts of RNA that are available from lasermicrodissected cells require a preamplification before generating a probe for array hybridization. Recently, we could demonstrate that SMART amplification of RNA is a fast method for preparing reliable probes for cDNA array analysis (Becker et al, 2001) . This result is in good agreement with experiments from other groups (Gonzalez et al, 1999; Spirin et al, 1999; Vernon et al, 2000) . Leethanakul et al (2000) and Fink et al (2002) applied this technique to material that was laser microdissected. We enhanced the previously published protocols by applying a real-time PCR-based amplification of the RNA. This way, we could directly monitor the quantity of the cDNA synthesized during the PCR process. In addition, this is not as RNA consuming as the original SMART protocol patented by Clontech, because we do not need to prepare two reactions (''tester and driver'') for finding the log-phase of the SMART-PCR by sacrificing one of the two reactions for agarose gel electrophoresis. Accordingly, there is no need of a subsequent cycling of the second reaction to the optimal number of cycles, which further reduces the time spent performing the protocol.
In order to demonstrate the reproducibility of our array hybridization method, we performed duplicate analyses of four cases. We could show a high reproducibility with only 6.9% (between 2.2% and 13%) of all spots above a certain threshold ''falsely'' indicating regulation. Similarly, Wang et al (2001) analyzed the relation between hybridization signal quality (i.e., signal/background ratio) and the consistency of array results. Depending on the quality of the hybridization signals they found up to 10% of low-quality hybridization signals, which is comparable with our data. The quality of array hybridization is influenced by many factors: printing of arrays, hybridization conditions, RNA quality, and RNA quantity. The last two are probably the most important factors for our experimental system, as the amount of RNA prepared from microdissected tissue is very limited and the material is exposed to conditions, which might be not optimal for RNA stability (e.g., hematoxylin and eosin staining). Although we control the amplification process by incorporation of SYBR Green, some amplification-born changes in the representation of single transcripts are possible and may affect the reproducibility (Becker et al, 2001) .
Taken together, in this transcriptome profiling we found mainly genes, which were induced with increasing stage of malignancy. In the stringently filtered data we found four genes, which showed a reduction of expression by a factor of 2 from nevi to metastases and a further eight genes, which were downregulated from melanoma towards metastases. But this regulation turned out to be not significant. Genes that were downregulated from nevi versus melanoma might be underrepresented, because we included only those genes in the statistical analysis that exhibited a normalized expression ratio of 5% averaged over all cases. This strategy ensures that the remaining genes are more robust candidates. Using a threshold lower than 5% would lead to more genes entering the analysis but also to the excess of false positives.
The average expression value of the four genes with the highest F-values in the univariate analysis of the array expression data within each class of melanocytic lesion was calculated (Table III) .
The average expression level of Trp2 is induced in later stages of progression in our set of cases (Table I: nos 1-22) . Interestingly, Trp2 has been found to be involved in the protection of melanoma cells against apoptosis (Nishioka et al, 1999) . In addition, it was detected to be abundantly expressed in glioblastoma lesions also deriving from cells of Table III . Classification results based on a multivariate analysis of: (A) array data a according to the genes with the highest F-values (Table II) , and (B) reverse transcription-PCR data b according to the expression values of eIF2c, UBE2I, and one EST (Table II neuroectodermal offspring (Udono et al, 2001) . As cancer cells are much more resistant against apoptosis than their untransformed counterparts, this might be a further mechanism switched on during melanoma progression. On the other hand, Orlow et al (1998) , compared the expression of Trp2 in melanoma and melanoma metastases in a syngenic mouse model and found a trend of downregulation of Trp2 in lesions of more aggressive local growth. At later stages of progression melanoma lesions tend to become amelanotic and, therefore, one could expect that the expression of some of the genes of the melanogenesis pathway are lost or downregulated (Orlow et al, 1995) . Even if melanin production is impaired, however, some of the pigment genes are still expressed varying from case to case (Sarantou et al, 1997) . eIF2g is a subunit of the eukaryotic translation initiation factor 2 (eIF2), which is a heterotrimeric G-protein required for GTP-dependent delivery of initiator tRNA to the ribosome. The eIF2g seems to be transiently upregulated in melanomas in comparison with nevi and metastasis. Erickson and Hannig (1996) showed that a mutation in the eIF2g gene leads to reduced growth rates. In addition they demonstrated that eIF2g is involved in overriding the lethal effect of the tumor suppressor gene PKR (Erickson et al, 2001) . These data suggest, that eIF2g may be involved in an important phase of developing autonomous melanoma growth.
Our observation of UBE2I being progressively upregulated (neviomelanomaometastases) underscores a possible influence of disrupted ubiquitine pathways in melanomas: Ubiquitinylation and subsequent degradation of the ubiquitinylated proteins by the proteasome machinery accounts for the regulation of proteins, such as cyclins, cyclin-dependent kinase inhibitors, p53, c-Jun and c-Fos (Ciechanover et al, 2000) . Loss of the fine-tuned regulation of the G 1 /S transition during the cell cycle is assumed to be an important part of melanoma progression (Kamb et al, 1994; Vogt et al, 1999; Bataille, 2000) . Therefore, our observation adds a new and possibly important aspect of modulating G 1 /S control in certain melanoma subsets. Seufert et al (1995) showed a direct involvement of UBE2I in cell cycle progression via interaction with cyclins.
Taken together, our data show, that the melanoma progression markers selected in this study for diagnostic and classification purposes, may also have a significant biologic role in melanoma progression, which needs further experimental evaluation.
Using the four genes described above, we were able to discriminate between nevi, melanomas, and melanoma metastases in 82% of all cases. One nevus was classified as a melanoma and two melanomas as nevi (Table III, Fig 3) . The metastases were included as a control group, even if there is no molecular biologic method necessary to differentiate between a lymph node metastasis and a nevus in the skin.
The potential usefulness of our marker set is further supported by the TaqMan validation. The expression profile of the marker genes detected by array analysis (Trp2, eIF2g, UBE2I, and the EST ) was analyzed by quantitative real-time reverse transcription-PCR. The TaqMan data classified the lesions with comparable accuracy (85%). Although this is not higher than the diagnostic accuracy using standard techniques, analyzing a higher number of cases based on the methodology provided in this work will enhance the quality of marker genes as the number of statistically significant variables included in the marker profile will grow.
A further conclusion from our data is that by assessing the number of genes in different functional groups within four clusters (Fig 2, legend) it becomes evident that most of the genes are regulated during progression from nevus towards melanoma (Fig 2) . This may indicate that the changes that occur in early transformation are partly conserved during further tumor progression. Hence, one can assume that profiling of the primary melanoma lesions will also disclose prognostic information in addition to its doubtless diagnostic value. The combination of LPC together with real-time PCR amplification of RNA appears to be sufficiently fast and reliable to become feasible for routine analysis of melano- cytic lesions. Although LPC might not be necessary for larger melanocytic lesions, it does have advantages as to the coverage of all, even early, small, incipient lesions in further academic studies. This could enhance the diagnosis and eventually the prognostic evaluation of melanocytic tumors in the future as it has been demonstrated in breast cancer patients (Ahr et al, 2002) .
Materials and Methods
Patients' material Before surgical treatment a written informed consent was obtained approved by the ethics committee. Tissue samples from excised melanocytic lesions, not needed for dermatopathologic evaluation, were snap frozen immediately after surgery in liquid nitrogen and stored at À801C (Table I) . For laser microdissection, cryosections (10 mm) were prepared, fixed, and stained as for routine hematoxylin and eosin staining using RNasefree conditions and kept on dry ice until LPC.
Laser microbeam microdissection and LPC Collection of melanocytic cells by LPC was performed as described (Westphal et al, 2002) . From all lesions, nests containing melanocytic cells were excised. Before catapulting, contaminating cells (e.g., infiltrating lymphocytes) were eliminated by laser ablation. A minimum of 200 cell equivalents (about 1000 visible cells) were harvested. The nests were taken from the complete tumor region to obtain a representative selection of the given tumor.
Isolation of total RNA The tissue obtained by LPC was lyzed in 50 mL RNA lysis buffer (Gentra Purescript RNA isolation kit, Gentra Systems, Minneapolis, Minnesota). RNA was isolated according to the protocol provided by the supplier and resuspended in 12 mL of RNase-free H 2 O.
Generation of radioactive probes for array hybridization Reverse transcription of the RNA, amplification of the cDNA and radioactive labeling of the cDNA was performed as described (Becker et al, 2001) with the following modifications: we now employed for the SMART amplification step as real-time controlled approach by using the Rotorgene real-time PCR machine (Corbett Research, Mortlake, NSW, Australia). The single-strand (ss) cDNA synthesis was performed according to the SMART-amplification protocol (Clontech, Heidelberg, Germany). The single-stranded cDNA was diluted with 40 mL of nuclease-free H 2 O bidest and treated for 7 min at 721C to denature the remaining RNA. Twenty microliters of the diluted ss cDNA was added as a template to the real-time amplification reaction containing 54 mL of H 2 O, 10 mL of 0.5 Â SYBR Green I (no. S-7563, Molecular Probes Inc., Eugene, Oregon), 10 mL of 10 Â Advantage PCR reaction buffer, 2 mL of deoxyribonucleoside triphosphate (10 mM), 2 mL of CDS primer, 2 mL of 50 Â Advantage polymerase mix (no. 8417-1, Clontech). During the PCR, the accumulation of the PCR products was monitored by measuring the intercalation of SYBR Green I into the DNA (Fig 1) in order to avoid normalization artifacts caused by overamplification. When the turning points of the logarithmic phase of the PCR reaction was reached (e.g., cycle 22 and 25, Fig 1a ' 'A'' and Fig 1 ''B'' , respectively) the reaction was stopped. Figure 1(a) shows the complete PCR amplification protocol of a typical experiment and the quality of the double-stranded cDNA synthesized after 22 (Fig 1a insert: lane A) and 25 cycles (Fig 1a insert:  lane B) in an agarose gel. Equal volumes of the two separate PCR reactions were loaded. The DNA smears in both lanes show that the amount and size of the amplified double-stranded cDNA were comparable. The double-stranded cDNA was purified with the Qiagen PCR purification kit (Qiagen, Hilden, Germany) and 100 ng was labeled radioactively with a 33 P-deoxycytidine triphosphate by standard random primed Klenow fragment synthesis.
Quantitative PCR For validation of the data obtained by array analyses the cDNA was subjected to quantitative real-time PCR using specific FAM labeled TaqMan probes (Applied Biosystems, Foster City, California) for detecting the following genes: tyrosinase-related protein 2 (AA292995), translation initiation factor 2g (AA448301), ubiquitine conjugating enzyme E2I (AA487197), and one expressed sequence tag (EST; AA030013). SCAMP2 (R32802), MDA-7 (AA281635), desmin (AA521431), CD68 (AA421296), syntaxin 5A (AA452374), proteoglycan 1 (AA278759), heme oxygenase (T71757), and RNA binding protein (AA054287). As a control for normalization of the PCR results a specific VIC labeled GAPDH probe was included in each reaction (no. 4310884E, Applied Biosystems). The PCR reaction was set up as recommended by the supplier.
Array hybridization and analysis The cDNA arrays (human GeneFilters no.GF200 no.1, Research Genetics, Huntsville, Alabama) were hybridized as described (Becker et al, 2001) . The hybridized membranes were exposed 36 h on a mounted phosphoimager screen (Amersham-Pharmacia Biotech, Freiburg, Germany). Data were acquired using the STORM 860 phosphoimager (Amersham-Pharmacia Biotech) and analyzed by the AIDA array analysis software package (Raytest, Berlin, Germany). Data were normalized by genomic spots included in every subgrid on the arrays. For a pairwise comparison of the normalized expression data an appropriate expression threshold (see below) was set in the AIDA comparison module. Genes below this threshold were not taken into account (Fig 1b: yellow spots) . As demonstrated earlier, genes regulated at least by a factor of 3 can be considered as truly regulated with very few exceptions (Becker et al, 2001) . Figure 1(b) shows an example displayed by the AIDA comparison module, where 3-fold downregulated genes are located below the green line and 3-fold upregulated genes above the red line in the array comparison view. The genes between both lines (Fig 1b: blue spots) are considered as nonregulated.
Statistical analysis of array data Genes reaching a minimum normalized expression ratio of at least 5% of the averaged signal over all cases were included in the statistical analysis. The statistical analysis of the filtered data was performed with the SPSS software (SPSS Inc., Chicago, Illinois). The most significant features in univariate analysis were used for a multivariate, stepwise discriminance analysis in order to discriminate nevi, melanomas, and melanoma metastases.
Functional clustering of genes For the genes passing the threshold defined above the averaged normalized expression ratio for each class of melanocytic lesions was calculated separately. The genes with ''known function'', in accordance with the gene information available in the OMIM database (http://www.ncbi. nlm.nih.gov), were sorted into functional groups ''metabolism'', ''signaling and cell cycle'', ''receptors and attachment'', ''others with known function''; those with no functional characterization were grouped as ''unclassified''. For each gene the pattern of regulation, i.e., upregulation or downregulation in nevi versus melanomas versus metastases, was determined as follows: (1) genes upregulated from nevi to melanomas; (2) genes upregulated from melanomas towards metastases; (3) genes upregulated from nevi to melanomas and further upregulated in metastases; and (4) upregulated from nevi to melanomas and downregulation in metastases. The number of genes for each pattern within its functional group was counted. 
